| Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors E Christodoulou, V Yellapantula, K O’Halloran, L Xu, JL Berry, JA Cotter, ... NPJ Precision Oncology 7 (1), 21, 2023 | 31 | 2023 |
| Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma E Christodoulou, M Rashid, C Pacini, A Droop, H Robertson, T Groningen, ... Pigment cell & melanoma research 34 (1), 122-131, 2021 | 18 | 2021 |
| NEK11 as a candidate high-penetrance melanoma susceptibility gene E Christodoulou, R van Doorn, M Visser, A Teunisse, M Versluis, ... Journal of Medical Genetics 57 (3), 203-210, 2020 | 15 | 2020 |
| Loss of wild-type CDKN2A is an early event in the development of melanoma in FAMMM syndrome E Christodoulou, RJ Nell, RM Verdijk, NA Gruis, PA van der Velden, ... Journal of Investigative Dermatology 140 (11), 2298-2301. e3, 2020 | 13 | 2020 |
| Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors K O’Halloran, V Yellapantula, E Christodoulou, D Ostrow, M Bootwalla, ... Neuro-Oncology Advances 5 (1), vdad077, 2023 | 12 | 2023 |
| m. 3685T> C is a novel mitochondrial DNA variant that causes Leigh syndrome J Jean, E Christodoulou, X Gai, B Tamrazi, M Vera, WG Mitchell, ... Molecular Case Studies 8 (2), a006136, 2022 | 2 | 2022 |
| Diagnosis and monitoring of pediatric cancer patients using low-pass whole genome and targeted sequencing of cell-free DNA V Yellapantula, E Christodoulou, K O’Hollaran, J Ji, L Xu, JL Berry, ... Cancer Research 83 (7_Supplement), 3322-3322, 2023 | 1 | 2023 |
| Microenvironmental changes co-occur with mosaic somatic clonal expansions in normal skin and esophagus tissues C Munugula, J Hu, E Christodoulou, V Yellapantula Frontiers in Oncology 12, 1021940, 2022 | 1 | 2022 |
| Targeted detection of sequence variants in cell-free DNA from cerebrospinal fluid in pediatric central nervous system tumors K O’Halloran, EE Crotty, E Christodoulou, SE Leary, A Miller, VA Paulson, ... Frontiers in Oncology 14, 1513073, 2025 | | 2025 |
| Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors K O’Halloran, E Christodoulou, VA Paulson, BL Cole, AS Margol, ... Clinical Chemistry 71 (1), 87-96, 2025 | | 2025 |
| OPEN ACCESS EDITED BY S Mahmood, L Zapata, JP Capp, V Yellapantula, C Munugula, J Hu, ... Tumour microenvironment in cancer research and drug discovery, 80, 2024 | | 2024 |
| Clinical applicability of targeted panel sequencing in liquid biopsies for disease diagnosis and monitoring of patients with pediatric solid tumors E Christodoulou, V Yellapantula, K O'Halloran, L Xu, JL Berry, F Navid, ... Cancer Research 84 (6_Supplement), 967-967, 2024 | | 2024 |
| Clinical Implementation of Low-Pass Whole-Genome Sequencing in Liquid Biopsies (LBSeq4Kids) for Disease Diagnosis and Monitoring of Childhood Solid Tumors E Christodoulou, J Biegel, V Yellapantula, D Xu, K O'Halloran, D Estrine, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S132-S132, 2023 | | 2023 |
| LBSeq4Kids-v2: A Pediatric-Specific Targeted Sequencing Assay for Cell-Free DNA (cfDNA) Profiling of Pediatric Brain and Solid Tumors V Yellapantula, E Christodoulou, D Xu, D Ostrow, J Ji, K O'Halloran, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S136-S136, 2023 | | 2023 |
| PD17-02 UNIVERSAL LOSS OF COMPLEX I IN ONCOCYTOMA IS ASSOCIATED WITH DEFECTIVE MITOPHAGY VIA ALTERED GLUTATHIONE METABOLISM L Lin, N Patel, B Wilde, L Fernandez-del-Rio, E Christodoulou, S Ohtake, ... Journal of Urology 209 (Supplement 4), e495, 2023 | | 2023 |
| Microenvironmental alterations co-occur with mosaic somatic clonal expansions in normal tissues C Munugala, J Hu, E Christodoulou, V Yellapantula Cancer Research 82 (12_Supplement), 3851-3851, 2022 | | 2022 |
| Evaluation of low-pass whole genome sequencing for the diagnosis and monitoring of patients with pediatric solid tumors E Christodoulou, D Ostrow, A Zdanowicz, V Yellapantula, C O'Connell, ... Cancer Research 82 (12_Supplement), 541-541, 2022 | | 2022 |
| 1. Clinical utility of low-pass whole genome sequencing (LP-WGS) and targeted panel sequencing in liquid biopsies for disease diagnosis and monitoring of patients with … JA Biegel, K O'Halloran, P Chiarelli, M Krieger, L Xu, JL Berry, F Navid, ... Cancer Genetics 264, 1, 2022 | | 2022 |
| DEVELOPMENT OF A CEREBROSPINAL FLUID LIQUID BIOPSY PLATFORM IN PEDIATRIC PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS K O'Halloran, D Ostrow, E Christodoulou, M Bootwalla, V Yellapantula, ... NEURO-ONCOLOGY 24, 152-152, 2022 | | 2022 |
| Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers E Christodoulou, M Visser, TP Potjer, N van der Stoep, ... Familial Cancer 18, 439-444, 2019 | | 2019 |